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Many people have multiple chronic conditions, which is termed multimorbidity.1 Multimorbidity is common, and people with 2 or more chronic 
conditions tend to have worse clinical outcomes and higher 
health care costs than people in  good health and those with a 
single chronic condition.2–5 Multimorbidity increases with 
age, and among older people it is felt to be a key driver of 
health care costs and the sustainability of health systems 
worldwide.6 Dementia also poses a major societal burden, 
and some evidence suggests that dementia is more common 
in the presence of multimorbidity.7–11 However, there are 
major knowledge gaps concerning the basic epidemiology of 
multimorbidity among older people; the clinical and eco-
nomic consequences of multimorbidity; the link between 
dementia, increasing age and multimorbidity; and the impact 
of the latter 3 interrelated factors on the capacity to live 
independently.12
We used a population-based data set of people aged 65 years 
or older and living in Alberta, a Canadian province with 4 million 
people, to characterize the frequency of dementia and 29 other 
common chronic conditions. We aimed to examined the joint 
associations between age, dementia and burden of morbidity with 
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Background: Little is known about how multimorbidity, dementia and increasing age combine to influence health outcomes or utiliza-
tion. Our objective was to examine the joint associations between age, dementia and burden of morbidity with mortality and other 
clinical outcomes. 
Methods: We did a retrospective population-based cohort study of all adults aged 65 years and older residing in Alberta, Canada, 
between 2002 and 2013. We used validated algorithms applied to administrative and laboratory data from the provincial health ministry 
to assess the presence/absence of dementia and 29 other morbidities, and their associations with mortality (our primary outcome), other 
clinical outcomes (emergency department visits, all-cause hospital admissions) and a proxy for loss of independent living (discharge to 
long-term care). Cox and Poisson models were adjusted for year-varying covariates. A 3-way interaction was modelled for dementia, the 
number of comorbidities, and age.
Results: There were 610 457 adults aged 65 years and older living in Alberta over the study period. Over median follow-up of 6.8 
years, 153 125 (25.1%) participants died and 5569 (0.9%) were discharged to long-term care. The prevalence of people with at least 
3 morbidities was 33.7% in 2003 and 50.2% in 2012. The prevalence of dementia rose from 6.2% in fiscal year 2003 to 8.3% in fiscal 
year 2012, representing a net increase of approximately 13 700 people. The likelihood of all 4 outcomes increased with age and with 
greater burden of morbidity; the presence of dementia further increased these risks. For example, the risk of mortality increased by 
1.54 to 6.38 in the presence of dementia, depending on age and morbidity burden. The risk associated with dementia was attenuated 
by increasing comorbidity.
Interpretation: Older age, multimorbidity and dementia are all strongly correlated with adverse health outcomes as well as a proxy 
for loss of independent living. The increasing prevalences of dementia and multimorbidity over time suggest the need for coordinated 
national strategies aimed at mitigating the health challenges associated with the aging of the population.
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mortality and other clinical outcomes (physician visits, emer-
gency department visits and hospital admissions) and especially 
with loss of capacity for independent living, defined by dis-
charge to a long-term care facility.
Methods
Data sources and cohort
Detailed methods are shown in the Appendix 1 (available at 
www.cmajopen.ca/content/5/3/E623/suppl/DC1). We used 
the Alberta Kidney Disease Network (AKDN) database, which 
incorporates data from Alberta Health (AH; the provincial 
health ministry) such as physician claims, hospital admissions 
and ambulatory care utilization; the Northern and Southern 
Alberta Renal Programs; and the clinical laboratories in 
Alberta. This database has been widely used13–15 because of its 
population-based coverage of a geographically defined area, 
which includes demographic characteristics, health services 
utilization and clinical outcomes. Additional information on 
the database is available elsewhere, including the validation of 
selected data elements.16 All people registered with AH were 
included in the database; all Alberta residents are eligible for 
insurance coverage by AH and more than 99% participate in 
coverage. The database was used to assemble a cohort of adults 
aged 65 years and older who resided in Alberta, Canada, 
between May 2002 and March 2013. We followed participants 
from May 2002, the date of their 65th birthday, or the date 
they registered with AH (whichever was later) until March 
2013, their death or their migration out of the province.
Comorbidities
We classified the presence and absence of 29 comorbidities on 
the basis of the availability of validated algorithms that could 
be applied to Canadian claims data and had positive predictive 
values of at least 70%.17 Dementia was one of the 29 condi-
tions and was defined by the presence of 1 hospital admission 
or 2 physician claims within 2 years (codes 290, 294.1 and 
331.2 from the International Classification of Disease, 9th 
revision [ICD-9] coding scheme and codes F00–F03, F05.1, 
G30 and G31.1 from the ICD-10 coding scheme).18 We also 
considered chronic kidney disease as a 30th condition, which 
was defined by mean annual estimated glomerular filtration 
rate (eGFR) below 60 mL/min per 173 m2 or the presence of 
albuminuria (albumin:creatinine ratio at least 30 mg/g, 
protein:creatinine ratio at least 150 mg/g or dipstick protein-
uria ≥ trace). Each participant was classified with respect to 
the presence or absence of dementia and 29 other chronic 
conditions for each fiscal year.19 If a participant developed a 
condition within a fiscal year or at any point previously (look-
back extended as far as April 1994 where records were avail-
able), he or she was classified as having the condition. 
Detailed methods for classifying morbidity status and the spe-
cific algorithms used are found elsewhere.17
Clinical outcomes
The primary outcome was time to all-cause death. Key sec-
ondary outcomes included the rate of physician visits (primary 
care physicians or specialists), the rate of emergency depart-
ment visits and the rate of hospital admissions. We also evalu-
ated loss of capacity for independent living, which was defined 
by first discharge to a public or private long-term care facility 
(e.g., nursing homes, auxiliary hospitals) following any hospi-
tal admission.
Statistical analyses
We did analyses with Stata MP 13.1 and reported baseline 
(first year within follow-up) descriptive statistics as counts and 
percentages or as medians and interquartile ranges, as appro-
priate. Secular trend of prevalent dementia was assessed using 
an autoregressive model of order 1. Analyses focused on the 
interactions between the specific exposures of dementia, num-
ber of nondementia morbidities, and age.
To examine the associations between dementia, increasing 
morbidity burden and age with the clinical outcomes, we used 
a number of models: Cox regression for mortality and long-
term care placements; and generalized linear regression using 
the Poisson distribution with a log link for the rates of physi-
cian claims, emergency department visits and hospital admis-
sions (all separately) and a random intercept term for partici-
pant. To meet Poisson modelling assumptions, we analyzed 
the doubling of events (claims, emergency department visits 
and hospital admissions) rather than absolute increments of 1 
event. All covariates were allowed to vary on a year-by-year 
basis.
Ethics approval
The study was approved by the universities of Alberta and 
Calgary.
Results
Characteristics of study participants
Participant flow is shown in Appendix 2, supplemental Figure 
S1 (available at www.cmajopen.ca/content/5/3/E623/suppl/
DC1). There were 610 457 participants aged 65 years or older; 
median follow-up was 6.8 years (range 1 d to 10.9 yr; 2.3% of 
participants migrated out of the province before the end of fol-
low-up). The median age of participants was 66 years at base-
line (range 65 to 110 yr), 53.2% were female, 1.4% were 
Aboriginal and 14.8% resided in a rural location (Table 1). The 
median number of nondementia morbidities was 2 (range 0 to 
16); 8.7% of participants had 5 or more morbidities.
The prevalence of dementia rose over time by approxi-
mately 0.2% per year from 6.2% in fiscal year 2003 to 8.3% 
in fiscal year 2012, representing a net increase of approxi-
mately 13 700 people. Adjustment for mean age did not atten-
uate the prevalence of dementia over time. For all age strata, 
the prevalence of dementia increased in parallel with the 
number of nondementia morbidities (Figure 1).
Unadjusted likelihood of outcomes
During follow-up, 153 125 (25.1%) participants died and 5569 
(0.9%) participants were discharged into long-term care. The 
rate of physician claims was 1795 per 100 person-years, the 
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rate of emergency department visits was 71 per 100 person-
years and the rate of hospital admissions was 24 per 100 person-
years. Unadjusted rates of mortality and discharge to long-
term care increased with increasing age for people with and 
without dementia. Unadjusted rates of physician visits, emer-
gency department visits and hospital admissions increased with 
Table 1: Demographic and clinical characteristics of participants at baseline
Group; % of participants*
Characteristic All
Age 65–74 yr Age 75–84 yr Age 85 yr+
Dementia
No 
dementia Dementia
No 
dementia Dementia
No 
dementia
No. 610 457 5424 435 151 8652 115 957 9772 35 501
Male 46.8 50.3 49.6 39.1 42.5 27.6 33.8
Aboriginal 1.4 3.1 1.6 0.6 0.6 0.4 0.5
Rural 14.8 13.2 15.7 10.6 13.3 10.7 11.8
No. of nondementia 
morbidities, median (IQR)
2 (1,3) 4 (2,5) 1 (0,3) 3 (2,5) 2 (1,3) 3 (2,5) 2 (1,4)
    None 23.0 5.5 25.6 6.7 17.8 6.6 19.2
    1 26.3 12.1 28.0 13.9 24.8 13.6 19.5
    2 21.0 15.0 21.1 15.9 21.8 18.2 19.6
    3 13.5 16.9 12.6 17.1 15.3 19.0 15.4
    4 7.6 14.0 6.5 14.6 9.2 14.9 10.8
    5 or more 8.7 36.6 6.2 31.8 11.2 27.7 15.5
Alcohol misuse 2.3 19.1 2.2 8.5 1.5 3.1 0.9
Asthma 3.0 6.7 2.7 5.2 3.5 4.5 3.6
Atrial fibrillation 6.9 11.9 4.5 19.5 10.6 23.4 15.5
Cancer, lymphoma 0.5 0.9 0.5 0.7 0.6 0.4 0.5
Cancer, metastatic 1.5 2.2 1.3 2.6 2.0 2.0 2.0
Cancer, nonmetastatic 5.8 6.0 5.2 8.6 7.4 7.1 6.8
Chronic heart failure 8.7 20.5 5.1 28.1 13.3 37.3 24.1
Chronic kidney disease 18.2 29.3 17.9 22.8 16.5 28.0 21.4
Chronic pain 9.7 11.2 9.7 9.6 10.5 7.1 8.4
Chronic pulmonary disease 16.3 33.6 14.1 31.3 20.1 29.0 21.2
Chronic viral hepatitis B 0.1 0.2 0.1 < 0.1 < 0.1 < 0.1 < 0.1
Cirrhosis 0.2 1.3 0.2 0.4 0.1 0.1 < 0.1
Constipation, severe 1.5 5.7 0.9 5.7 2.0 6.2 3.5
Depression 7.3 34.5 6.5 27.2 6.9 19.5 6.8
Diabetes 16.8 29.6 16.8 23.6 16.6 17.5 13.1
Epilepsy 1.2 10.5 1.1 3.9 0.9 2.2 0.7
Hypertension 54.1 62.1 50.6 65.3 62.3 65.0 62.2
Hypothyroidism 11.3 16.3 10.5 18.0 12.4 18.8 13.5
Inflammatory bowel disease 0.8 1.2 0.9 0.9 0.6 0.7 0.4
Irritable bowel syndrome 1.8 3.8 1.8 3.0 1.6 2.0 1.4
Multiple sclerosis 0.5 3.8 0.6 1.0 0.3 0.6 0.2
Myocardial infarction 4.3 7.9 3.8 8.0 5.1 7.2 5.8
Parkinson disease 1.4 10.6 0.7 10.8 1.9 8.2 2.4
Peptic ulcer disease 0.4 1.5 0.3 1.6 0.7 1.2 0.8
Peripheral vascular disease 1.8 4.5 1.5 3.9 2.4 3.0 2.4
Psoriasis 0.7 1.6 0.7 0.9 0.6 0.7 0.5
Rheumatoid arthritis 3.0 5.0 2.6 4.7 3.7 4.5 3.7
Schizophrenia 0.9 16.2 0.7 6.0 0.4 3.4 0.3
Stroke or TIA 9.6 30.8 6.9 33.8 12.6 33.6 17.8
Note: IQR = interquartile range, TIA = transient ischemic attack.
*Unless stated otherwise.
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age among people without dementia but decreased with age 
among those with dementia (Appendix 3, Supplemental Table 
1 [available at www.cmajopen.ca/content/5/3/E623/suppl/
DC1]).
Adjusted likelihood of outcomes
The likelihood of all clinical outcomes (death, physician claims, 
emergency department visits, all-cause hospital admissions, dis-
charge to a long-term care facility) tended to increase with 
greater burden of morbidity (Figure 2), regardless of the pres-
ence of dementia The exceptions were all-cause mortality (for 
which there was evidence of a J-shaped relation among those 
with dementia, with the lowest risk of death observed among 
those with 2 or 3 morbidities) and for discharge to a long-term 
care facility among people with dementia (the likelihood of 
which decreased with increasing morbidity) (Figure 2).
The presence of dementia increased the risk of all clinical out-
comes, regardless of age and level of morbidity; the excess risk 
was especially pronounced for mortality and for discharge to a 
long-term care facility (Figure 2). However, the magnitude of 
the excess risk for discharge to long-term care that was associated 
with dementia appeared to decrease with increasing age and 
morbidity (Table 2; Figure 2). For example, among people with 
no morbidities, the hazard ratios (HRs) for discharge to long-
term care associated with dementia (v. no dementia) were 179.85 
(95% confidence interval [CI] 127.52–253.66), 65.57 (95% CI 
48.64–88.40) and 22.00 (95% CI 17.15–28.24) among people 
aged 65–74, 75–84 and at least 85 years, respectively. Among 
people aged 85 years and older, the HRs associated with demen-
tia for discharge to long-term care for those with 1, 2 and 3 mor-
bidities were 3.48 (95% CI 3.13–3.88), 2.29 (95% CI 2.14–2.45) 
and 1.63 (95% CI 1.56–1.72), respectively. The magnitude of the 
excess risks for physician visits, emergency department visits or 
all-cause hospital admissions that were associated with dementia 
all appeared to decrease with increasing morbidity, but the risks 
were not consistently modified by age (Table 2; Figure 2). These 
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Figure 1: Relative proportion of participants with dementia in fiscal year 2011 by age and number of morbidities. The top row, from left to right, 
shows participants age 65–74 years, age 75–84 years and age 85 years or older. The bottom row, from left to right, shows participants age 
85–89 years, age 90–94 years and age 95 years or older. Within each graph, the bars from left to right show the number of morbidities that 
participants in that age group have, starting at 0 morbidities and ending at 5 or more. The width of each bar indicates the percentage of partici-
pants in each group. The height of each bar indicates the unadjusted percentage of participants with dementia (blue) and the percentage of 
participants without dementia (green).
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Figure 2: Adjusted risk multiplier for number of morbidities by age and presence of dementia. The risk multipliers are presented by age, number of 
morbidities and dementia. They are adjusted for the number of morbidities, dementia, age, sex, Aboriginal status and rural/urban residence, and they 
are relative to people age 65–74 years with no nondementia morbidities. These models include 3-way and 2-way interactions terms for dementia, 
age and number of morbidities. The first panel shows the hazard ratios for mortality by the number of morbidities. The second, third and fourth panels 
similarly show the rate ratios for physician visits, ED visits and hospital admissions, respectively. The last panel shows the hazard ratios for discharge 
to long-term care from hospital. The blue diamond symbols indicate participants with dementia and the red squares indicate those without dementia. 
The horizontal bars depict 95% confidence intervals. Along with the risk of mortality and discharge to long-term care, the figure shows the likelihood 
of a 2-fold increase in the risk of the outcomes with repeat events (i.e., physician visits, ED visits, hospitalizations) that is associated with dementia. 
For example, a 2-fold increase in the number of physician visits is 1.57 times more likely among those who are aged 65–74 years who have 1 comor-
bibity and do not have dementia than in those of similar age who have no comorbitiies and do not have dementia. Note: ED = emergency depart-
ment, LTC = long-term care.
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patterns were also seen when only participants aged 85 years and 
older were considered (Appendix 4, supplemental Table 2 [avail-
able at www.cmajopen.ca/content/5/3/E623/suppl/DC1]).
In contrast to these relative trends in the prognostic 
importance of dementia, the absolute percentages of partici-
pants who died and of those discharged to a long-term care 
facility (rather than home) increased in parallel with age and 
number of chronic conditions; the presence of dementia acted 
as a risk multiplier for both of these adverse outcomes, 
regardless of age or morbidity burden (Figure 3). For exam-
Table 2: Adjusted risk multiplier for dementia by age and number of morbidities
Age group;  
no. of 
morbidities
No. of 
participant-
years (%)
Mortality,
HR (95% CI)
Physician 
visits,
RR (95% CI)
ED visits, 
RR (95% CI)
Hospital 
admissions, 
RR (95% CI)
Discharge to 
long-term care,
HR (95% CI)
Age 65–74 yr 2 093 043
    None 409 872
(19.6)
6.38
(5.86–6.95)
1.79
(1.73–1.85)
2.40
(2.14–2.70)
5.22
(4.38–6.22)
179.85
(127.52–253.66)
    1 514 511
(24.6)
5.02
(4.74–5.31)
1.29
(1.27–1.32)
2.07
(1.94–2.20)
4.02
(3.70–4.38)
63.74
(53.52–75.91)
    2 462 717
(22.1)
4.43
(4.23–4.63)
1.23
(1.21–1.25)
1.93
(1.84–2.02)
3.14
(2.95–3.33)
28.52
(25.34–32.10)
    3 320 038
(15.3)
3.41
(3.27–3.56)
1.21
(1.19–1.23)
1.65
(1.59–1.71)
2.70
(2.57–2.83)
11.54
(10.51–12.68)
    4 183 217
(8.8)
2.55
(2.44–2.66)
1.20
(1.18–1.22)
1.46
(1.41–1.51)
2.19
(2.09–2.28)
5.41
(4.99–5.88)
    5 or more 202 688
(9.7)
1.80
(1.76–1.84)
1.20
(1.19–1.21)
1.35
(1.33–1.38)
1.79
(1.75–1.83)
2.16
(2.07–2.26)
Age 75–84 yr 1 441 821
    None 146 923
(10.2)
4.68
(4.46–4.91)
1.87
(1.83–1.92)
2.80 
(2.60–3.01)
5.98
(5.36–6.67)
65.57
(48.64–88.40)
    1 240 053
(16.7)
3.66
(3.55–3.77)
1.31
(1.29–1.32)
1.95
(1.88–2.03)
3.52
(3.33–3.72)
18.20
(15.93–20.79)
    2 301 412
(20.9)
3.19
(3.12–3.27)
1.23
(1.22–1.24)
1.75
(1.70–1.80)
2.99
(2.88–3.10)
6.41
(5.94–6.92)
    3 271 780
(18.9)
2.74
(2.68–2.80)
1.21
(1.20–1.22)
1.54
(1.50–1.57)
2.45
(2.38–2.53)
3.73
(3.52–3.95)
    4 191 442
(13.3)
2.31
(2.26–2.36)
1.20
(1.19–1.21)
1.42
(1.39–1.45)
2.03
(1.98–2.08)
2.12
(2.02–2.23)
    5 or more 290 211
(20.1)
1.74
(1.72–1.76)
1.20
(1.20–1.21)
1.27
(1.25–1.28)
1.61
(1.59–1.63)
1.30
(1.26–1.33)
Age ≥ 85 yr 610 548
    None 70 565
(11.6)
6.48
(6.18–6.79)
4.48
(4.37–4.59)
4.71
(4.33–5.12)
10.48
(9.24–11.89)
22.00
(17.15–28.24)
    1 60 779
(10.0)
2.20
(2.13–2.26)
1.50
(1.48–1.52)
1.73
(1.65–1.80)
3.12
(2.93–3.32)
3.48
(3.13–3.88)
    2 97 128
(15.9)
2.14
(2.10–2.19)
1.35
(1.34–1.37)
1.48
(1.44–1.52)
2.53
(2.44–2.63)
2.29
(2.14–2.45)
    3 107 891
(17.7)
2.03
(1.99–2.07)
1.30
(1.29–1.31)
1.27
(1.25–1.30)
2.01
(1.95–2.07)
1.63
(1.56–1.72)
    4 93 241
(15.3)
1.85
(1.81–1.88)
1.26
(1.25–1.27)
1.18
(1.16–1.20)
1.60
(1.56–1.65)
1.26
(1.21–1.31)
    5 or more 180 944
(29.6)
1.54
(1.52–1.55)
1.23
(1.23–1.24)
1.09
(1.07–1.10)
1.32
(1.30–1.34)
1.08
(1.06–1.11)
Note: CI = confidence interval, ED = emergency department, HR = hazard ratio, RR = rate ratio. Ratios are adjusted for sex, Aboriginal status and 
rural/urban residence. These models include 3-way and 2-way interaction terms for dementia, age and number of morbidities. The table shows the 
likelihood of a 2-fold increase in the risk of the outcomes with repeat events (i.e., physician visits, ED visits, hospital admissions) that is associated 
with dementia, along with the risk of mortality and discharge to long-term care. For example, in participants age 65–74 years with no comorbidities, 
the presence of dementia is 1.79 times more likely to be associated with a 2-fold increase in the number of physician visits, compared with 
participants of similar age and with no comorbidities, but without dementia.
Research
CMAJ  OPEN
 CMAJ OPEN, 5(3) E629
ple, the absolute likelihood of discharge to a long-term care 
facility (over a 5-year period) was 0.6%, 3.3% and 12.0% for 
participants aged 65–74, 75–84 and at least 85 years, respec-
tively; among participants 85 years and older, these propor-
tions were 1.7%, 2.6%, 4.8% and 10.7% for those with 2, 3, 
4, or  5 or more morbidities but without dementia, and 
28.0%, 35.6%, 37.6% and 46.9% for those with 2, 3, 4, or 5 
or more morbidities as well as dementia.
Interpretation
In this population-based study of more than 600 000 community- 
dwelling people aged 65 years and older, we examined how 
increasing age and burden of chronic conditions modify the 
association between dementia and adverse health outcomes. 
As previously reported, the risk of poor outcomes increases in 
parallel with age and the number of morbidities.2,20 We found 
that the presence of dementia acted as a risk multiplier across 
all age and morbidity strata, leading to worse health outcomes, 
especially for the risks of death or discharge to a long-term 
care facility. Although the clinical impact of dementia is 
already considerable, we also found a relatively slow but con-
sistent increase in the prevalence of dementia over time: 0.2% 
per year, or approximately 13 700 people per decade in 
Alberta. To put this statistic into context, the current capacity 
of Alberta’s long-term care facilities is approximately 14 000 
people. While not all people with dementia will lose the capac-
ity to live independently, these findings have clear implications 
for health systems and for the people responsible for planning 
and providing long-term care.
As a result of lower birth rates and longer life expectancy, the 
proportion of older people in the general population is steadily 
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Figure 3: Relative proportion of deaths versus discharges to a long-term facility after 5 years by age, presence/absence of dementia, and 
number of morbidities. For this analysis, age and the presence/absence of dementia and other morbidities were assessed in fiscal year 2006. 
Clinical status (death; discharge to LTC facility) was assessed 5 years later in fiscal year 2011. The top row shows participants with no demen-
tia. The bottom row shows participants with dementia. The left-most column shows participants age 65–74 years, the middle column shows 
participants age 75–84 years and the right-most column shows participants age 85 years or older. Within each graph, the bars from left to right 
show the number of morbidities by group, starting at 0 morbidities and ending at 5 or more. The width of each bar indicates the percentage of 
participants in each group. The height of each bar indicates clinical status: the unadjusted percentage of participants who were alive without 
discharge to LTC facility (dark blue), alive but discharged to LTC placement after a hospital admission (grey), deceased but discharged to 
LTC placement previously (light green), or deceased and never discharged to LTC placement (dark green). Note: LTC = long-term care.
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increasing worldwide.7 Longer lifespans and the potential soci-
etal benefits associated with these demographic changes are to 
be celebrated, but population aging also poses numerous chal-
lenges for policy-makers. Although the age-related natures of 
both multimorbidity and dementia are well known, few studies 
have examined how the interplay between age, multimorbidity 
and dementia influences health outcomes or the capacity for 
independent living. Available studies demonstrate that increased 
morbidity burden is associated with higher prevalence and 
severity of dementia and cognitive impairment,8–11,21–24 but they 
are limited by their relatively small sample sizes and lack of lon-
gitudinal follow-up for clinical outcomes or resource use. Possi-
ble explanations for the high prevalence of comorbidities in peo-
ple with dementia include common risk factors (e.g., unhealthy 
diet), a common causal pathway (e.g., atherosclerosis), adverse 
effects of medications used to treat medical morbidity, or other 
iatrogenic factors (e.g., subclinical stroke following angioplasty 
for coronary disease).
The landmark House of Lords report entitled Ready For 
Aging? focused on the implications of the aging population for 
the United Kingdom in 2020–2030,25 and it singled out 
dementia as an age-related condition that will require specific 
policy remedies aimed at prevention, management, harm 
reduction and social inclusion. Our findings strongly validate 
this conclusion and suggest that such policy remedies could 
produce considerable benefits. Areas of focus for such strate-
gies could include health promotion (reducing the risk of 
dementia and other morbidities), self-care (perhaps through 
increased use of technology to improve function and reduce 
disability), tailored care for older patients with multimorbidity 
(accounting for interactions between conditions and the medi-
cations used to treat them, as well as the side effects of medi-
cines that are more commonly used with increasing age), bet-
ter integration between health and social care (to delay or 
prevent loss of independent living), and ensuring that the 
workforce has sufficient capacity and expertise to meet the 
needs of older people.26–28 Additional research should focus on 
how best to achieve these objectives.
Limitations
Our study has important strengths, including its use of a 
large population-based database from a setting with univer-
sal health care coverage, its use of validated algorithms for 
ascertaining the presence or absence of morbidity and its 
rigorous analytical methods. However, our study also has 
several potential limitations that should be considered when 
interpreting results. First, like all studies using administra-
tive data, it is possible that there was residual confounding 
by unmeasured characteristics (e.g., smoking, body mass 
index, physical activity, and the extent of support from fam-
ily members and other caregivers), and not all data elements 
have been validated. Second, since participants must use 
medical services to be diagnosed with chronic conditions, 
the use of administrative data to identify morbidities will 
underestimate the true population burden of dementia and 
other morbidities. Similarly, the excess risk associated with 
milder forms of dementia not requiring medical attention 
may be less pronounced than suggested here. In addition, we 
did not have algorithms for certain potentially important 
morbidities such as osteoporosis and frailty. However, given 
that utilization of medical services increases with age, our 
focus on people aged 65 years and older at baseline should 
reduce the extent of such underestimation. Third, when 
applied to ICD-10 claims, the validated algorithm that we 
used for dementia has a positive predictive value of 93% and 
sensitivity of 67%, as compared with a clinical gold stan-
dard.18 Therefore, our findings will underestimate the true 
prevalence of dementia in Alberta. Fourth, our claims data-
base allowed us to identify only people who were discharged 
from hospital to a long-term care facility. Since some older 
people enter long-term care facilities directly from home, 
our findings will underestimate the total percentage of peo-
ple within each age stratum who eventually require long-
term care. Fifth, we did not report on the incidence of 
dementia, because our design better captures prevalent cases; 
patients who develop dementia but die before they are cap-
tured as having dementia in claims data will be incorrectly 
omitted from estimates of dementia incidence but correctly 
omitted for estimates of dementia prevalence. Sixth, we 
studied people from a single Canadian province and our 
findings may not apply to other settings, although the demo-
graphic and health care challenges faced in this province are 
shared with all developed and many developing countries.
Conclusion
Like multimorbidity, the prevalence of dementia increases 
with increasing age, and age, burden of morbidity and demen-
tia together are strongly correlated with adverse health out-
comes and a proxy for loss of independent living. These find-
ings and the secular trends in the population prevalence of 
dementia suggest the need for coordinated national strategies 
to mitigate the health challenges associated with the aging of 
the general population.
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